Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway
Zhiguo Zhang(Kosair Children's Hospital), Shudong Wang(Jilin University), Shanshan Zhou(First Hospital of Jilin University), Xiaoqing Yan(Kosair Children's Hospital), Yonggang Wang(First Hospital of Jilin University), Jing Chen(Kosair Children's Hospital), Nicholas Mellen(University of Louisville), Maiying Kong(University of Louisville), Junlian Gu(University of Louisville), Yi Tan(Wenzhou Medical University), Yang Zheng(Jilin University), Lu Cai(University of Louisville)
Cited by 189
Abstract
Related Papers
Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus
Luuk J. Rijzewijk, R.W. van der Meer, Johannes W. A. Smit et al.|Journal of the American College of Cardiology|2008|551